JPH01268560A - Preparation of calcium phosphate ceramics implant - Google Patents

Preparation of calcium phosphate ceramics implant

Info

Publication number
JPH01268560A
JPH01268560A JP63095662A JP9566288A JPH01268560A JP H01268560 A JPH01268560 A JP H01268560A JP 63095662 A JP63095662 A JP 63095662A JP 9566288 A JP9566288 A JP 9566288A JP H01268560 A JPH01268560 A JP H01268560A
Authority
JP
Japan
Prior art keywords
calcium phosphate
org
molded body
kneaded
injection molding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63095662A
Other languages
Japanese (ja)
Other versions
JP2787829B2 (en
Inventor
Hideki Aoki
秀希 青木
Masaru Akao
赤尾 勝
Katsuyoshi Saito
勝義 斉藤
Miharu Hata
美治 秦
Toru Shiba
徹 斯波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advance Co Ltd
Original Assignee
Advance Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Co Ltd filed Critical Advance Co Ltd
Priority to JP63095662A priority Critical patent/JP2787829B2/en
Publication of JPH01268560A publication Critical patent/JPH01268560A/en
Application granted granted Critical
Publication of JP2787829B2 publication Critical patent/JP2787829B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

PURPOSE:To enhance strength and to reduce the lowering of strength in a living body, by kneading a calcium phosphate powder with a thermoplastic org. material and performing the injection molding of the kneaded mixture to degrease and sinter the molded one. CONSTITUTION:A calcium phosphate powder and an org. material are kneaded to be subjected to injection molding and the obtained molded body is degreased and sintered to prepare a calcium phosphate ceramics implant. For example, 5-50wt.% of the org. material is added to the calcium phosphate powder and the resulting mixture is well melted and kneaded at 100-250 deg.C using a press kneader. The kneaded mixture is ground and granulated to be charged in an injection molding machine and injected in an implant body mold preliminarily processed into a predetermined shape to be subjected to molding. The molded body is taken out to be introduced into an atmospheric pressure or pressurized degreasing furnace and the org. material is slowly degassed and removed at 350-600 deg.C for 2-7 days. At last, the molded body wherein the org. material is removed is slowly sintered at 800-1,300 deg.C for 1-3 days in a vacuum, atmospheric pressure or pressurized sintering furnace to obtain a dense ceramic molded body.

Description

【発明の詳細な説明】 本発明は、インブラントに関する。[Detailed description of the invention] The present invention relates to an implant.

生体親和性に優れたハイドロキシアパタイトを使用して
形成されるインブラントは、その用途により様々な複雑
な形状に成形加工しなければならないが、−軸ブレスや
ラバープレス法などの従来の方法だと、成形性、寸法精
度及び表面滑沢性など品質を向上させるためには、仕上
げ加工や表面研摩などの後加工を必要とする。
Implants made using hydroxyapatite, which has excellent biocompatibility, must be molded into various complex shapes depending on the intended use. In order to improve quality such as formability, dimensional accuracy, and surface smoothness, post-processing such as finishing and surface polishing is required.

そのため、リン酸カルシウムセラミックスのように強度
の比較的小さいセラミックスの場合、後加工により表面
に無数のマクロクラックやマイクロクラックができ、強
度の低下を招く。さらに、生体内での溶解による強度低
下もより一層大きくなり、実用上大きな問題となってい
る。
Therefore, in the case of ceramics with relatively low strength, such as calcium phosphate ceramics, numerous macrocracks and microcracks are formed on the surface during post-processing, leading to a decrease in strength. Furthermore, the strength decreases further due to in vivo dissolution, which is a major problem in practical use.

他方、複雑な形状を有する加工品を大量生産できる最も
効率的な方法であるという長所を有する射出成形法をセ
ラミックス材料に通用する試みが近年なされているが、
製造コストが高くつく他、混練する有機材料の選択、脱
脂条件の決定など、技術的にむずかしい点を多く含んで
いる点で、実用に達しているとは言えない。さらに、セ
ラミック原料粉末自体の比表面積が大きい材料は、より
多くの有機材料を必要とするため、ますます技術的に困
難となっていた。ましてハイドロキシアパタイトは、セ
ラミック材料の中では比表面積が格段に大きく、種々の
物質の吸着能にすぐれ、液クロ用吸着カラムとして広く
用いられているほどで、射出成形用材料としては、はと
んど成形不能と言われている原料の一つであった。
On the other hand, attempts have been made in recent years to apply injection molding to ceramic materials, which has the advantage of being the most efficient method for mass-producing processed products with complex shapes.
In addition to high production costs, this method cannot be said to be of practical use because it involves many technically difficult points, such as the selection of organic materials to be kneaded and the determination of degreasing conditions. Furthermore, materials with a large specific surface area of the ceramic raw powder itself require a larger amount of organic material, which has become increasingly technically difficult. Furthermore, hydroxyapatite has a much larger specific surface area than other ceramic materials, has excellent adsorption ability for various substances, and is widely used as an adsorption column for liquid chromatography, making it an outstanding material for injection molding. It was one of the raw materials said to be impossible to mold.

我々は鋭意努力の結果、リン酸カルシウム粉末を熱可塑
性有機材料に混練した後、射出成形を行ない、さらに脱
脂及び焼結を行なった緊密なセラミック成形体が、−次
加工のみで十分な成形性、均質性、寸法精度、表面滑沢
性などを有し、又、材料表面にマクロクラックやマイク
ロクラックをつくらないことから強度が向上し、又、生
体内での強度低下ら少ないことを知見し、本発明に到達
したものである。
As a result of our diligent efforts, we have successfully kneaded calcium phosphate powder into a thermoplastic organic material, injection molded it, degreased it, and sintered it to create a compact ceramic body with sufficient moldability and homogeneity through subsequent processing. This book was developed based on the findings that the strength of the material is improved because it has excellent properties such as hardness, dimensional accuracy, and surface smoothness, and does not create macrocracks or microcracks on the surface of the material. This invention has been achieved.

材料及び製法 本発明に於けるCa/Pモル比が15〜2.0であるリ
ン酸カルシウム化合物は、例えばハイドロキシアパタイ
ト、リン酸三カルノウム、リン酸四カルシウム等が具体
的に例示され、その製法は、例えば湿式法等で合成した
スラリーを噴霧乾燥し、0.1〜150μの粒径をら一
〕球状微粒子とした乙のを300〜1300℃で焼成し
た方法が提示される。
Materials and manufacturing method Specific examples of the calcium phosphate compound having a Ca/P molar ratio of 15 to 2.0 in the present invention include hydroxyapatite, tricarnoum phosphate, tetracalcium phosphate, etc., and the manufacturing method thereof is as follows: For example, a method is proposed in which a slurry synthesized by a wet method or the like is spray-dried to form fine spherical particles with a particle size of 0.1 to 150 μm, and the resulting particles are fired at 300 to 1300°C.

噴霧乾燥粉以外にボールミルやサンプルミル、ジェット
ミル、アトマイザ−などの種々の粉砕法による破砕粉や
造粒粉、あるいは熱分解法、アルコキシド法、乾式法な
どの別な合成法に5ノーる造粒粉を用いてらよい。又、
牛骨や魚骨など天然の骨や歯を高温で焼結した焼成粉を
用いろことらできる。
In addition to spray-dried powder, crushed powder or granulated powder can be produced using various pulverization methods such as ball mills, sample mills, jet mills, and atomizers, or other synthesis methods such as thermal decomposition, alkoxide methods, and dry methods. It is better to use grain flour. or,
It can be made by using sintered powder made by sintering natural bones and teeth such as cow bones and fish bones at high temperatures.

また、Mg、Zr、Fe、Ti、Si、Srなどこ)陽
イオンや、Cl2−、F−、I−、CO3’−などの陰
イオンをθ〜lO%程度含むものを用いてしよい。
Further, a material containing cations (such as Mg, Zr, Fe, Ti, Si, Sr, etc.) and anions such as Cl2-, F-, I-, CO3'- in an amount of about θ to 10% may be used.

次に、このリン酸カルシウム化合物粉末に、結合剤、解
こう剤、潤滑剤、可塑剤、湿潤剤、消泡剤、カップリン
グ剤、界面活性剤、保護コロイド剤などの目的で種々の
有機材料を適宜混練する。結合剤としては、ポリエチレ
ン、ポリプロピレン、エチレン−酢酸ビニル共重合体(
1号VA)、エチレン−アクリレート共重合体(EEA
)、アクリル系樹脂、ボリスチレノ、SMR樹脂、セル
ロース系樹脂、ポリエステルなどが例示される。
Next, various organic materials are appropriately added to this calcium phosphate compound powder for the purposes of binding agents, peptizers, lubricants, plasticizers, wetting agents, antifoaming agents, coupling agents, surfactants, protective colloid agents, etc. Knead. As a binder, polyethylene, polypropylene, ethylene-vinyl acetate copolymer (
No. 1 VA), ethylene-acrylate copolymer (EEA
), acrylic resin, Boris tyreno, SMR resin, cellulose resin, polyester, etc.

潤滑剤としては、パラフィンワックス、マイクロクリス
タリンワックスなどのワックス類、高級脂肪酸、脂肪酸
アシド、脂肪酸エステルなとが例示される。又、可塑剤
としてはジブチルフタレート、ブチルベンノンフタレー
トなどが例示される。
Examples of the lubricant include waxes such as paraffin wax and microcrystalline wax, higher fatty acids, fatty acid acids, and fatty acid esters. Examples of plasticizers include dibutyl phthalate and butylbennon phthalate.

これら有機材料をリン酸カルシウム粉末に対して5〜5
0重量%添加し、加圧ニーグーを用いて100〜250
℃でよく融解、混練する。これを破砕し、粒状にしたら
のを射出成形機に投入し、予め所定の形状に加工したイ
ンブラント体成形金型中に射出成形する。次に、取り出
した成形体を常圧又は加圧脱脂炉に入れ、2〜7日間で
350〜600℃でゆっくり何機材料を脱気除去する。
5 to 5 of these organic materials to calcium phosphate powder
Add 0% by weight and use a pressurized knee gun to add 100 to 250
Melt and knead well at °C. This is crushed and made into granules, which are then put into an injection molding machine and injection molded into an implant molding die that has been previously processed into a predetermined shape. Next, the molded body taken out is placed in a normal pressure or pressurized degreasing furnace, and the material is slowly degassed at 350 to 600°C for 2 to 7 days.

最後に、このa機分を除いた成形体を真空、常圧又は加
圧焼結炉で1〜3日間で800〜1300°Cでゆっく
り焼結し、緻密なセラミック成形体を得る。又は、熱間
等方圧縮(1−IIP)を用いて、150〜800℃、
10〜15,000t/cm”で焼結させろこともでき
る。
Finally, the molded body except for part a is slowly sintered at 800 to 1300°C for 1 to 3 days in a vacuum, normal pressure, or pressure sintering furnace to obtain a dense ceramic molded body. Or, using hot isostatic compression (1-IIP), 150 to 800 °C,
It is also possible to sinter at 10 to 15,000 t/cm.

インブラントは、医学及び歯学の分野で、生体内に埋入
し長期にわたって留置し臨床治療に用いる器具又は装置
を指す。代表的なセラミックインブラントとしては経皮
端子(PerctaneousDevice)、人工血
管(Artificial VascularPros
thesis)、ブラッドアクセスデバイス(B100
Fl Access Device)、人工歯根(Ar
tiricialtooth root)、人工気管(
Artificial Trachea)、人1−骨(
Artificial Bone Prosthesi
s)、センサ−(S (! n s o r )などが
ある。
In the fields of medicine and dentistry, an implant refers to an instrument or device that is implanted in a living body and left in place for a long period of time to be used for clinical treatment. Typical ceramic implants include Percutaneous Devices and Artificial Vascular Pros.
thesis), Blood Access Device (B100
Fl Access Device), artificial tooth root (Ar
tiritialtooth root), artificial trachea (
Artificial Trachea), Human 1-Bone (
Artificial Bone Prosthesis
s), sensor (S (!nsor), etc.).

実験1 湿式法で合成した後、ジェットミルで粉砕したハイドロ
キンアパタイトに第1表の割合で打機材料を加えた。
Experiment 1 Drilling material was added to hydroquine apatite synthesized by a wet method and then ground in a jet mill in the proportions shown in Table 1.

第  1  表 これを、東洋精機製混練機ラボブラストミルで十分に混
練した後、山域精機製射出成形機MD−20型で円筒状
成形体が得られる金型に射出成形した。これを鴻製作所
製脱脂炉S I−I K S −2型で550℃で約5
日間有機分の除去を行なった。
Table 1 This was sufficiently kneaded using a Labo Blast Mill, a kneader manufactured by Toyo Seiki, and then injection molded into a mold capable of obtaining a cylindrical molded body using an injection molding machine MD-20 manufactured by Yamaguchi Seiki. This was heated at 550°C for about 50 minutes in a degreasing furnace S I-I K S-2 type manufactured by Kou Seisakusho.
Organic components were removed for several days.

シリコニット高熱工業製焼成炉B M −1530型で
1250℃で焼成し、外径7 、6mra、内径3.5
tam、長さ1OIII11の円筒形緻密焼結体を得た
Sintered at 1250°C in a siliconite high-temperature industrial firing furnace model BM-1530, with an outer diameter of 7.6 mra and an inner diameter of 3.5 mra.
A cylindrical dense sintered body with tam and length of 1OIII11 was obtained.

インストロン材料試験機112a型で圧管テストを行な
い、圧縮引張強度を求めた結果を第1図に示す。比較と
して、東洋油圧製−軸プレス機で、約1 t/cI11
″の圧力で圧縮成形した円柱体を旋盤及びボール盤を用
いて二次加工し、上記と同様の円筒体を得た後、同様に
して焼結体としたものを用いた。
A pressure tube test was carried out using an Instron material testing machine model 112a, and the results of compressive tensile strength are shown in FIG. For comparison, a Toyo Hydraulic shaft press machine produces approximately 1 t/cI11.
A cylindrical body compression-molded at a pressure of 100 mm was subjected to secondary processing using a lathe and a drill press to obtain a cylindrical body similar to that described above, and then a sintered body was used in the same manner.

この結果、本性による成形体は、−軸ブレスによる圧縮
成形後、二次加工により円筒形とした乙のに比べて1.
5〜2倍近い強度があった。
As a result, the molded body according to the present invention was made into a cylindrical shape by secondary processing after compression molding using a -axis press, compared to B.
It was 5 to 2 times as strong.

又、圧縮成形のみで二次加工を行なっていない円柱形の
ものと比べても同等以上の強度を持っていることが明ら
かとなった。
It was also revealed that the strength was equal to or higher than that of a cylindrical product that was only compression molded and did not undergo secondary processing.

実験2 湿式法で合成した後、噴霧乾燥した粉末に第2表の割合
で有゛機材料を混練した。
Experiment 2 Organic materials were kneaded in the proportions shown in Table 2 to the powder that had been synthesized by a wet method and then spray-dried.

第2表 これを曲げ試験試料成形用金型で成形後、実 ・験1と
同様にして焼結した。これらを成人背部皮下に埋入し、
1ケ月後及び3ケ月後に取り出した。これらの試料の3
点曲げ強度を高車オートグラフA 0200OAで測定
した結果を第2図に示す。対照として、−軸プレス機で
圧縮成形の後、焼結した円板形焼結体をアイソメットダ
イヤモンドカッター11−180で切断したものを用い
た。
Table 2: Bending test sample After molding with a mold, it was sintered in the same manner as in Experiment 1. These are implanted subcutaneously in the back of an adult.
They were taken out after 1 month and 3 months. 3 of these samples
The point bending strength was measured using a Kosha Autograph A 0200OA, and the results are shown in Figure 2. As a control, a disc-shaped sintered body that had been compression-molded using a -axis press and then cut using an isometric diamond cutter 11-180 was used.

本性で製造した試験片は、対照に比べて約9%強度が大
きかった。又、埋入lケガ後の強度低下は対照に比べて
小さく、本性が約8%、対照が約13%であった。この
ことがら、本性が二次加工を必要とする従来の方法に比
べて強度が大きく、生体内での強度低下も少ないことが
わかった。
The test specimens prepared with the present invention had approximately 9% greater strength than the control. In addition, the decrease in strength after the implant injury was smaller than that of the control, about 8% for the original and about 13% for the control. From this, it was found that the strength is greater than that of conventional methods which inherently require secondary processing, and the strength decreases less in vivo.

以上のことから、本性はリン酸カルシウムセラミックス
を用いた長期生体内埋入用インブラント体の成形法とし
て優れていることがわかった。
From the above, it was found that the present invention is an excellent method for forming implants for long-term in-vivo implantation using calcium phosphate ceramics.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明の実施例に於ける圧縮引張強度を示すグ
ラフ、第2図は本発明の実施例に於ける曲げ強度を示す
グラフである。 特許出願人 株式会社アドバンス 第2図 1ネ斌 メ里人#8 関(激onぺS)
FIG. 1 is a graph showing compressive tensile strength in an example of the present invention, and FIG. 2 is a graph showing bending strength in an example of the present invention. Patent Applicant: Advance Co., Ltd. Figure 2 1 Neimerito #8 Seki (Geki Onpe S)

Claims (1)

【特許請求の範囲】[Claims] (1)リン酸カルシウム化合物粉末と有機材料を混練し
、射出成形を行なったのち、脱脂及び焼結を行なうこと
を特徴とするリン酸カルシウムセラミックスインプラン
トの製造方法。
(1) A method for producing a calcium phosphate ceramic implant, which comprises kneading a calcium phosphate compound powder and an organic material, performing injection molding, followed by degreasing and sintering.
JP63095662A 1988-04-20 1988-04-20 Manufacturing method of calcium phosphate ceramic implant Expired - Lifetime JP2787829B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63095662A JP2787829B2 (en) 1988-04-20 1988-04-20 Manufacturing method of calcium phosphate ceramic implant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63095662A JP2787829B2 (en) 1988-04-20 1988-04-20 Manufacturing method of calcium phosphate ceramic implant

Publications (2)

Publication Number Publication Date
JPH01268560A true JPH01268560A (en) 1989-10-26
JP2787829B2 JP2787829B2 (en) 1998-08-20

Family

ID=14143706

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63095662A Expired - Lifetime JP2787829B2 (en) 1988-04-20 1988-04-20 Manufacturing method of calcium phosphate ceramic implant

Country Status (1)

Country Link
JP (1) JP2787829B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995015775A1 (en) * 1993-12-10 1995-06-15 Kabushiki Kaisya Advance Implantation material and process for producing the same
WO2000045867A1 (en) * 1999-02-02 2000-08-10 Dr. H.C. Robert Mathys Stiftung Implant comprising calcium cement and hydrophobic liquid
WO2016206180A1 (en) * 2015-06-24 2016-12-29 东莞天天向上医疗科技有限公司 Bioresorbable bone repair material and application and manufacturing method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6021763A (en) * 1983-07-15 1985-02-04 ティーディーケイ株式会社 Artificial bone material
JPS62167250A (en) * 1986-01-17 1987-07-23 工業技術院長 Manufacture of high strength calcium phosphate sintered bodyby slip casting process
JPS62270164A (en) * 1986-03-05 1987-11-24 株式会社アドバンス Substitute material for repairing living body hard tissue
JPH026375A (en) * 1988-03-31 1990-01-10 Asahi Optical Co Ltd Production of porous ceramic material and green compact for use in said production

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6021763A (en) * 1983-07-15 1985-02-04 ティーディーケイ株式会社 Artificial bone material
JPS62167250A (en) * 1986-01-17 1987-07-23 工業技術院長 Manufacture of high strength calcium phosphate sintered bodyby slip casting process
JPS62270164A (en) * 1986-03-05 1987-11-24 株式会社アドバンス Substitute material for repairing living body hard tissue
JPH026375A (en) * 1988-03-31 1990-01-10 Asahi Optical Co Ltd Production of porous ceramic material and green compact for use in said production

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995015775A1 (en) * 1993-12-10 1995-06-15 Kabushiki Kaisya Advance Implantation material and process for producing the same
US5766247A (en) * 1993-12-10 1998-06-16 Kabushiki Kaisya Advance Process for producing a bioimbedding material
WO2000045867A1 (en) * 1999-02-02 2000-08-10 Dr. H.C. Robert Mathys Stiftung Implant comprising calcium cement and hydrophobic liquid
WO2016206180A1 (en) * 2015-06-24 2016-12-29 东莞天天向上医疗科技有限公司 Bioresorbable bone repair material and application and manufacturing method thereof

Also Published As

Publication number Publication date
JP2787829B2 (en) 1998-08-20

Similar Documents

Publication Publication Date Title
US5306673A (en) Composite ceramic material and method to manufacture the material
JP3362267B2 (en) Bioimplant material and method for producing the same
US4846838A (en) Prosthetic body for bone substitute and a method for the preparation thereof
EP0253506B1 (en) Implant material and process for producing the same
Ebaretonbofa et al. High porosity hydroxyapatite foam scaffolds for bone substitute
CN1126464A (en) α-tricalcium phosphate ceramics and production method thereof
US5453227A (en) Process for the production of ceramic prostheses
US4207306A (en) Process for producing polycrystalline ceramic oxides
KR101239112B1 (en) Method for Preparing Porous Titanium-Hydroxyapatite Composite
RU2190502C2 (en) Method of production of porous material on base of titanium nickelide for medicine
JP2787829B2 (en) Manufacturing method of calcium phosphate ceramic implant
JPH0214866A (en) Solution of calcium phosphate compound ceramic precursor and production thereof
JPS6212680A (en) Block-form apatite sintered body
KR101132991B1 (en) Sintered body of titanium compound
US4772573A (en) High-strength sintered article of calcium phosphate compound, raw material for production of said sintered article, and method for production of said sintered article
JPS6179462A (en) Porous artificial bone material
KR19980072300A (en) Biomaterials using shellfish and artificial living hard tissues using them
KR101221378B1 (en) Osteotribe and method of manufacturing the same
JPS61270249A (en) Tetracalcium phosphate settable composition
JP3308355B2 (en) Method for producing sintered carbonated apatite
JPH05220177A (en) Implant made of ti base sintered alloy having excellent bioaffinity
Rafai et al. EFFECT OF PEG AND PVA BINDERS ON THE CNC MILLING OF HYDROXYAPATITE FOR BIOMEDICAL APPLICATIONS
JP2581942B2 (en) Method for producing calcium phosphate ceramic sintered body
JPH037630B2 (en)
JPS6278143A (en) Whitlockite sintered body and manufacture